| Deborah Jael Morton, MD | |
|
3810 Triple Crown Dr, Murfreesboro, TN 37127-6536 | |
| (615) 604-5710 | |
| Not Available |
| Full Name | Deborah Jael Morton |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 34 Years |
| Location | 3810 Triple Crown Dr, Murfreesboro, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336180488 | NPI | - | NPPES |
| 01600320 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 195273 (New York) | Secondary |
| 261QU0200X | Clinic/center - Urgent Care | 41772 (Tennessee) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Current Care Pa | 9739260019 | 429 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | American Current Care Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194914085 PECOS PAC ID: 9739260019 Enrollment ID: O20080301000091 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Hendersonville 280 Indian Lake Boulevard |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407299639 PECOS PAC ID: 3072756733 Enrollment ID: O20130827000943 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Lebanon 1705 West Main Street Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417390642 PECOS PAC ID: 2769625425 Enrollment ID: O20130827000998 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Brentwood (210 Franklin Road),llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053654947 PECOS PAC ID: 2163665472 Enrollment ID: O20130904000995 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Cool Springs (100 International Drive), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720320997 PECOS PAC ID: 7315180684 Enrollment ID: O20130905000694 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Hermitage (5225 Old Hickory Boulevard), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871836148 PECOS PAC ID: 0941444855 Enrollment ID: O20130916000341 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Donelson (2372 Lebanon Road), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528301223 PECOS PAC ID: 2264676782 Enrollment ID: O20130923000418 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Nashville (west End Avenue), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699118828 PECOS PAC ID: 9234373762 Enrollment ID: O20130923000553 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Murfreesboro (1340 Broad Street), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437491602 PECOS PAC ID: 8325282882 Enrollment ID: O20130924000083 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Carespot Of Nashville (2001 Glen Echo Road), Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699018051 PECOS PAC ID: 9436393709 Enrollment ID: O20130926000773 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Entity Name | Urgent Care Enterprise Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477087658 PECOS PAC ID: 5496998155 Enrollment ID: O20170808002289 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Deborah Jael Morton, MD 3810 Triple Crown Dr, Murfreesboro, TN 37127-6536 Ph: (615) 604-5710 | Deborah Jael Morton, MD 3810 Triple Crown Dr, Murfreesboro, TN 37127-6536 Ph: (615) 604-5710 |
News Archive
A selection of health policy stories from Washington state, Virginia, Wisconsin, West Virginia and Florida. The proposal, numbered 2725 in the House and 6513 in the Senate, would create a new appeal process for when county officials decline to order an involuntary commitment. In those situations, immediate family members could ask a Superior Court judge about the case (Rosenthal, 2/3).
Mylan Inc. and Pfizer Inc. today announced that Meridian Medical Technologies, a Pfizer subsidiary, has entered into a settlement agreement with Intelliject and Sanofi-Aventis that will resolve pending patent litigation related to Intelliject's 505(b)(2) new drug application (NDA) for its epinephrine auto-injector known as e-cue, which will be manufactured and marketed by Sanofi-Aventis.
In a national survey of U.S. medical practices, SK&A Information Services, Inc., a leading provider of healthcare information and research, found that office managers wield as much influence as lead physicians in determining the policy for allowing industry sales representatives to visit with physicians.
Maxygen, Inc., a biopharmaceutical company, today announced financial and business results for the quarter and year ended December 31, 2011.
Some simple interventions used by pediatricians were enough to change a parent's perspective about a child's being overweight or obese, and change the parent's behaviors at home to reduce those risks.
› Verified 2 days ago